Independent innovation gradually becomes the core values ​​of mainstream pharmaceutical companies。July 18，Xiamen，At the annual National Pharmaceutical Industry Top 100 List Unveil List，Unite Tiansi Group by SFDA Southern Medical Economics Research Institute、Kangyuan Pharmaceutical、Stone Medicine Group、Xianyin Pharmaceutical、Steps Pharmaceutical、Qilu Pharmaceutical、Green Leaf Pharmaceutical、A total of 9 domestic mainstream innovative pharmaceutical companies in China and Yuekang Pharmaceutical initiative、The "China Innovation Pharmaceutical Enterprise Development Alliance" will be officially My stake betting appstake online sports bettingestablished here。"Different from other alliances is，The alliance we formed should really pass the investigation and research，Completion of common problems encountered in the field of pharmaceutical innovation、Practical research analysis，Platform for innovative construction for the pharmaceutical industry，and integrate the advantageous resources among members，Drives more innovative enterprises development。"One of the founders of the alliance、Yan Xijun, chairman of Tzuhiki Group, Yan Xijun said in a word，The original intention of the first batch of pharmaceutical companies to form alliance。
 
Collective sound is weak
 
For independent innovation，Ren Jin Sheng, chairman of Xianyin Pharmaceutical, feels deeply。From their practice,，7 patent medicines have been approved in recent years，But only 2 medicines really belong to independent research and development，The remaining 5 medicines are through cooperation，Especially for international cooperation。Due to the small volume of local companies，They chose joint research and development，And with Shi Guibao、Merhado established cooperation，Even cooperate with some small and medium -sized companies with source innovation，Find ME-Better encouraged by national policies、ME-New Product。Visible，Pharmaceutical technology cooperation has gradually entered a good realm。
 
But，Innovation is not only manifested at the technical level，Policies and regulations、Enterprise Management、stake betting appstake sports betting appInnovation in market transformation and other links is the shortcoming of such innovative companies that really feel confused。"The current pricing mechanism、Bidding and procurement policy of various places，Factors in market transformation in the medical insurance directory，It hurts many companies with innovative innovation。But regrettable is，The true status of the current industry、Puzzle and voices still lack effective and high -end vocal platform。""，Zhao Chao, president of Bao Chang Pharmaceutical, bluntly pointed out the collective confusion of the industry。
 
He thinks，Limited power of a single enterprise，Step Chang Pharmaceutical has 72 new drugs with independent intellectual property rights represented by brain -hearted capsules，and more than 98%of the output value comes from the product independently developed，But in the process of marketization, it is also affected by policies and regulations，It is quite necessary to establish a government communication mechanism。Once there is a new policy adjustment，RDPAC will collectively make their own voice to policy makers。Compared with，Domestic enterprises have not yet formed a real industry demand consciousness。
 
Alliance prototype first appears
 
The reporter learned，At present, mainstream innovation companies generally have a wish to change the loose structure，Try to help the industry's development through joint organization。Yan Xijun analyzed: "China's current mainstream innovative Stake Sports Bettingenterprises stake sports betting apphave not formed a strong service agency，Specializing in studying specific technical problems，Specialized and government departments how to support China's national pharmaceutical industry innovation and upgrade，How to learn from foreign advanced technology for my use，Provide consultation reference for relevant decision -making for relevant government departments。”
 
In this context，Chinese Innovation Pharmaceutical Enterprise Development Alliance came into being。Zhao Chao pointed out，Innovation alliance is to actively participate in the industry's relevant policies to formulate，Then promote the development of innovative drugs in my country and the healthy development of the industry。"New alliances should pay attention to the path of successful foreign enterprises and the mainstream model of social medical management development，Research on China's industrial situation，Relying on the technical system of the Southern Institute and the Medical Economic News、Information System and Media System，Provide front -line reform evaluation for the policy department，and give our opinions。Really achieve RDPAC，Inner innovation alliance。"Zhao Chao。
 
In the interview，Green Leaf Pharmaceutical、Qilu Pharmaceutical and other relevant persons in charge of the first batch of units also agreed with this。The aforementioned company thinks，The value created by the Health Alliance for the organization of the organization is sustainable，instead of short -sighted，They have high expectations for stake betting appthe upcoming Stake Sports Bettingalliance。The reporter also learned，The alliance intends to be officially established，Study on the hot issues of the industry，and form an industrial development white paper directly submitted to the relevant ministries and commissions of the State Council，Provide evaluation basis for industry policy makers，to awaken the confusion that ethnic pharmaceutical companies encountered on the innovation chain。